Stolt-Nielsen Limited (0OHK)
London Exchange · UK · prices in NOK · close of 15 Oct 2026
Key indicators
| Last close | NOK 352.00 |
|---|---|
| 52-week range | 281.60 – 373.50 |
| Return, 1 month / 3 months | +0.8% / +7.7% |
| Return, 1 year / 3 years | +8.0% / +60.6% |
| Trend | Uptrend |
| RSI (14) | 49 |
| Volatility (1 year) | 33.5% |
| Worst drawdown (1 year) | -17.5% |
| Average daily value traded | 0.28M NOK |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stolt-Nielsen Limited is a shipping and logistics company that transports bulk liquid chemicals and other specialty liquids using a fleet of parcel tankers. It also provides tank container services for smaller shipments and operates bulk liquid storage terminals. Its customers are chemical producers, refiners and other industrial firms that need to move liquids safely across international routes. The company is incorporated in Bermuda and runs its operations from offices in several countries.
Stolt-Nielsen Limited trades under the code 0OHK on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stolt-Nielsen Limited (0OHK) trades on the London Exchange in UK. It last closed at NOK 352.00 on 15 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 771 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.0% and over the last three months it rose 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.9% | ||
| From 52-week high | -5.8% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.7% | ||
| 6-month return | 12.6% | ||
| 12-month return, skipping the last month | 7.2% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.5% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.28M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 87 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +0.8% |
| 3 months | +7.7% |
| 6 months | +12.6% |
| 1 year | +8.0% |
| 3 years | +60.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 340.24 / 317.45 |
|---|---|
| Golden / death cross (60 days) | Golden, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.23 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | NOK 9.3414 |
| 19 Nov 2025 | NOK 10.1780 |
| 23 Apr 2025 | NOK 13.0529 |
| 21 Nov 2024 | NOK 13.8162 |
| 24 Apr 2024 | NOK 16.4995 |
| 22 Nov 2023 | NOK 10.8025 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.